Compare EXEL & DPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXEL | DPZ |
|---|---|---|
| Founded | 1994 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 11.6B |
| IPO Year | 2000 | 2004 |
| Metric | EXEL | DPZ |
|---|---|---|
| Price | $59.89 | $310.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 30 |
| Target Price | $54.87 | ★ $373.15 |
| AVG Volume (30 Days) | ★ 2.0M | 720.5K |
| Earning Date | 11-03-2026 | 10-13-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | ★ 57.95 | 5.27 |
| EPS | 1.60 | ★ 8.21 |
| Revenue | $452,477,000.00 | ★ $4,939,994,000.00 |
| Revenue This Year | $10.09 | $4.94 |
| Revenue Next Year | $13.62 | $2.28 |
| P/E Ratio | ★ $37.33 | $37.64 |
| Revenue Growth | N/A | ★ 4.96 |
| 52 Week Low | $33.76 | $282.00 |
| 52 Week High | $60.83 | $442.35 |
| Indicator | EXEL | DPZ |
|---|---|---|
| Relative Strength Index (RSI) | 62.95 | 53.67 |
| Support Level | $54.38 | $297.56 |
| Resistance Level | N/A | $322.12 |
| Average True Range (ATR) | 1.64 | 7.15 |
| MACD | 0.07 | 3.21 |
| Stochastic Oscillator | 69.54 | 90.10 |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Domino's is the world's largest pizza chain, surpassing $20 billion in system sales with over 22,100 stores across more than 90 markets at the end of 2025. Around 33% of its units are in the US. The business is 99% franchised. Domino's operates through three segments: supply chain (60% of revenue), US stores (33%), and international franchises (7%). The firm generates the bulk of its revenue by supplying food to stores in the US and Canada through a vertically integrated network of 25 manufacturing and supply chain facilities, which primarily produce and distribute dough, and collecting brand royalties and marketing fees from franchisees. Domino's also generates revenue from sales at company-owned stores.